Sparsentan is supplied with detailed characterization data compliant with regulatory guideline. Sparsentan can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sparsentan.
Information
The product can be used as reference standards and further traceability against pharmacopeial standards can be provided based on feasibility.